133 related articles for article (PubMed ID: 3115334)
1. Functional heterogeneity of B-CLL lymphocytes: dissociated responsiveness to growth factors and distinct requirements for a first activation signal.
Karray S; Merle-Béral H; Vazquez A; Gerard JP; Debre P; Galanaud P
Blood; 1987 Oct; 70(4):1105-10. PubMed ID: 3115334
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: relationship to B-cell-derived lymphokines.
Benjamin D; Bazar LS; Wallace B; Jacobson RJ
Cell Immunol; 1986 Dec; 103(2):394-408. PubMed ID: 3100061
[TBL] [Abstract][Full Text] [Related]
3. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents.
Ghaderi AA; Richardson P; Cardona C; Millsum MJ; Ling N; Gillis S; Ledbetter J; Gordon J
Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369
[TBL] [Abstract][Full Text] [Related]
5. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
Karray S; Emilie D; Galanaud P
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
[TBL] [Abstract][Full Text] [Related]
7. Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cells.
Perri RT
Blood; 1986 Apr; 67(4):943-8. PubMed ID: 3485460
[TBL] [Abstract][Full Text] [Related]
8. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.
Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL
J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271
[TBL] [Abstract][Full Text] [Related]
9. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells.
Vazquez A; Auffredou MT; Gerard JP; Delfraissy JF; Galanaud P
J Immunol; 1987 Oct; 139(7):2344-8. PubMed ID: 3116080
[TBL] [Abstract][Full Text] [Related]
10. The proliferative response of B cell chronic lymphocytic leukemia to interleukin 2: functional characterization of the interleukin 2 membrane receptors.
Touw I; Dorssers L; Löwenberg B
Blood; 1987 Jun; 69(6):1667-73. PubMed ID: 3107631
[TBL] [Abstract][Full Text] [Related]
11. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation.
Hivroz C; Grillot-Courvalin C; Labaume S; Miglierina R; Brouet JC
Eur J Immunol; 1988 Nov; 18(11):1811-7. PubMed ID: 3144454
[TBL] [Abstract][Full Text] [Related]
12. Large granular lymphocytes from B-chronic lymphocytic leukemia patients inhibit normal B cell proliferation.
Perri RT; Kay NE
Am J Hematol; 1989 Jul; 31(3):166-72. PubMed ID: 2500849
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a human B cell line that proliferates in response to B cell growth factor.
Abe H; Rossio JL; Ruscetti FW; Matsushima K; Oppenheim JJ
J Immunol Methods; 1986 Jun; 90(1):111-23. PubMed ID: 2423613
[TBL] [Abstract][Full Text] [Related]
15. B8.7 antigen expression on B-CLL cells and its relationship to the LMW-BCGF responsiveness.
Karray S; Leprince C; Merle-Beral H; Debre P; Richard Y; Galanaud P
Leuk Res; 1990; 14(9):809-14. PubMed ID: 2232853
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of recombinant IL 2 and interferon-gamma on the proliferation of human monoclonal lymphocytes.
Karray S; Vazquez A; Merle-Beral H; Olive D; Debre P; Galanaud P
J Immunol; 1987 Jun; 138(11):3824-8. PubMed ID: 3108376
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.
Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M
Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907
[TBL] [Abstract][Full Text] [Related]
18. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
[TBL] [Abstract][Full Text] [Related]
19. Positive effects of interferon-alpha on B cell-type chronic lymphocytic leukemia proliferative response.
Karray S; Delfraissy JF; Merle-Beral H; Wallon C; Debre P; Galanaud P
J Immunol; 1988 Feb; 140(3):774-8. PubMed ID: 3257503
[TBL] [Abstract][Full Text] [Related]
20. Identification of a major 50-kDa molecular weight human B-cell growth factor with Tac antigen-inducing activity on B cells.
Kawano M; Matsushima K; Oppenheim JJ
Cell Immunol; 1987 Aug; 108(1):132-49. PubMed ID: 3111722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
